Hanmi Pharm’s incrementally modified drug ‘Esmezole’ mentioned in USP
‘Esomezol(generic name: esomeprazole strontium tetrahydrate),’ an incrementally modified drug developed by Hanmi Pharm, will be mentioned in the United States Pharmacopeia.
Pharmacopoeia, a book with legal force, is an official publication containing a list of medicines approved by a nation or a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
